Trials / Not Yet Recruiting
Not Yet RecruitingNCT06916169
A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042
An Open-label, Randomized, Fasting, Single, Group 2, Stage 2, Cross-over Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042 in Healthy Adult Volunteers
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.
Detailed description
To evaluate the pharmacokinetic characteristics and safety profiles of AG2304 compared with coadministration AG23041 and AG23042 after a single oral dose administration in healthy Korean subjects under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AG2304 | AG2304, Single-dose Oral Administration |
| DRUG | AG23041 and AG23042 | AG23041/AG23042, Single-dose Oral Administration |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2025-09-01
- Completion
- 2025-09-01
- First posted
- 2025-04-08
- Last updated
- 2025-04-08
Source: ClinicalTrials.gov record NCT06916169. Inclusion in this directory is not an endorsement.